Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer
about
Current Status of Long Non-Coding RNAs in Human Breast CancerPersistent Exposure to Porphyromonas gingivalis Promotes Proliferative and Invasion Capabilities, and Tumorigenic Properties of Human Immortalized Oral Epithelial Cells.H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysisLong noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells.LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.CCAT1 promotes laryngeal squamous cell carcinoma cell proliferation and invasion.Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21Long nonding RNA UCA1 regulates neural stem cell differentiation by controlling miR-1/Hes1 expression.Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis.Identification of an lncRNA‑miRNA‑mRNA interaction mechanism in breast cancer based on bioinformatic analysis.Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells.Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph.LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway.Deciphering the roles of lncRNAs in breast development and disease.Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis.The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant)
P2860
Q28079880-856B6910-2796-4F99-86B9-CB4370FCBF45Q30252984-4B0B8196-85BF-4932-8574-95136032A296Q33557802-A958DB06-A4B7-4A16-80E9-8CE458FE08F5Q33778789-469EC73D-1DD8-43C9-9AEB-C5DA80A063E8Q37641798-C7DC40EF-8F96-45ED-BBBF-F0B28AC9C010Q38709621-2CB8DF9E-B767-447F-9B77-FEC1588CA954Q39200386-CB4E9BB3-D673-4D93-9BA2-2CDBE80C8AF0Q41364283-98F30C5D-7B19-4157-BE12-544FAD023370Q41549331-1315A58D-A753-48D1-9874-810DF6232892Q42177374-5D47FE45-3BA8-4A7E-BF4C-CA083BE2B263Q42679163-59A9AB9D-79BF-4768-B716-12A765093171Q46839870-D1EC90A5-96EC-411D-81A3-A8F05951433BQ47329036-C608C55A-83AF-4AF2-8E41-9F184FF872FFQ49307799-563F9124-7ED4-428B-A9D0-D1819E18B28DQ49317008-E3048835-866A-44DB-BADC-126765F9EA62Q54975879-0D41180D-6883-465B-9FE4-4EC26B43019FQ55004353-3F09B51C-C426-4AA0-AA6D-6987581E47FBQ55516569-9DD72919-7A2A-440A-99D7-EB33ED5FAD82Q55669583-F7ADCED7-8AC1-41F6-8BAE-CCD5847ECBF7Q58789108-21BFA91D-CBBA-4C57-B01F-F805D4356419
P2860
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overexpression of long non-cod ...... in patients with breast cancer
@ast
Overexpression of long non-cod ...... in patients with breast cancer
@en
type
label
Overexpression of long non-cod ...... in patients with breast cancer
@ast
Overexpression of long non-cod ...... in patients with breast cancer
@en
prefLabel
Overexpression of long non-cod ...... in patients with breast cancer
@ast
Overexpression of long non-cod ...... in patients with breast cancer
@en
P2093
P2860
P921
P1476
Overexpression of long non-cod ...... in patients with breast cancer
@en
P2093
P2860
P304
P577
2015-08-01T00:00:00Z